Welcome to the Oncomine Blog
Evaluating NGS technologies for in-house comprehensive genomic profiling
11/13/2024 |
Research
In everyday practice, it is common for pathology labs to evaluate >50% cytological specimens across solid tumors especially in lung and pancreatic...
-
The Importance of Detecting the Most Fusions Across the Most Patients
In recent years, we’ve seen an increasing number of new therapies emerge that target gene fusions in...